Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer
Emily E. Bosco(Cincinnati Children's Hospital Medical Center), David A. Tice
Cited by 17
Related Papers
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
|Journal of Clinical Investigation|2006|192
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
|Journal of Clinical Investigation|2023|49